Study of the Safety & Efficacy of Cefdinir & Levofloxacin for

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

See also
Status	Clinical Trial	Phase
Completed	`NCT00930488` - Treatment of Patients With Acute Sinusitis	N/A
Completed	`NCT00147914` - Comparison Study Between Cefdinir & Amoxicilline/Clavulanate in Acute Sinusitis and Assessment of Quality of Life	Phase 4
Recruiting	`NCT03766568` - Single Use Device Endoscopy for the Diagnosis of Acute Bacterial Rhinosinusitis in Primary Care	N/A
Completed	`NCT04588376` - Improving Antibiotic Prescribing for Pediatric Respiratory Infections by Family Physicians With Peer Comparison	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT00930488 - Treatment of Patients With Acute Sinusitis

N/A

Completed

NCT00147914 - Comparison Study Between Cefdinir & Amoxicilline/Clavulanate in Acute Sinusitis and Assessment of Quality of Life

Phase 4

Recruiting

NCT03766568 - Single Use Device Endoscopy for the Diagnosis of Acute Bacterial Rhinosinusitis in Primary Care

N/A

Completed

NCT04588376 - Improving Antibiotic Prescribing for Pediatric Respiratory Infections by Family Physicians With Peer Comparison

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00645073
Study type	Interventional
Source	Abbott
Contact
Status	Completed
Phase	Phase 4
Start date	November 2003

Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms